Methods of treating diseases and disorders by targeting multiple kinases

Details for Australian Patent Application No. 2004293035 (hide)

Owner Signal Pharmaceuticals, LLC

Inventors Sakata, Steven T.; Narla, Rama K.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004293035

PCT Pub. Number WO2005/051308

Priority 60/608,929 19.11.03 US; 60/523,859 19.11.03 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051308 Priority application(s): WO2005/051308

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293040-Slide clamp

2004293034-EphA2 agonistic monoclonal antibodies and methods of use thereof